MedTrace Logo

National Wilm's Tumor Study Late Effects

NCT00228696 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2013-11-26

No results posted yet for this study

Summary

The Late Effects Study is being conducted in order to answer scientific questions and to serve as a resource for Wilms tumor patients and their families. Patients must have been enrolled on the NWTS-5 protocol in order to be eligible for this study.

Conditions

  • Wilm's Tumor

Interventions

OTHER

none, screening only

Screening protocol with no intervention

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Howard Katzenstein, MD · Children's Healthcare of Atlanta

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2010-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00228696 on ClinicalTrials.gov